<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>Emergent BioSolutions Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Emergent BioSolutions Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/Emergent_BioSolutions_Inc-3813382</link>
<lastBuildDate>Thursday, August 21, 2008 5:32:00 PM</lastBuildDate>
<alacra:xlsid>3813382</alacra:xlsid>
<alacra:company>Emergent BioSolutions Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/ccbn/T1900033</link><guid isPermaLink="false">ccbn/T1900033</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen and welcome to the Second Quarter #### Emergent BioSolutions, Inc. Earnings Conference Call. My name is Katina and I will be your coordinator for today. At this time all participants are in a listen-only mode. We will conduct a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to our host for today's call, Mr. Robert Burrows. Please proceed. ...

</description><pubDate>8/8/2008 9:15:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Emergent BioSolutions Inc Q2 2008 Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">EBS</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Emergent BioSolutions Inc Q2 2008 Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1900033</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-26577223</link><guid isPermaLink="false">newstex/PRN-0005-26577223</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Jul. ##, #### (PR Newswire delivered by Newstex) -- MERIDAN, Conn., July ## /PRNewswire/ -- Emergent BioSolutions, Inc. (NYSE: EBS) has instituted a lawsuit related to its funding of Protein Sciences Corporation (PSC) and EBS's proposed...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04006000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">09015000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07013000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016047</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016007</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016002</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016019</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04007003</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">02002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003006</newstex:cat><pubDate>7/10/2008 3:06:06 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18012000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18001000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Protein Sciences Responds to Emergent BioSolutions Lawsuit</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-26577223</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">EMERGENT BIOSOLUTIONS INC.</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">EBS</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1861285</link><guid isPermaLink="false">ccbn/T1861285</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the Emergent Biosolutions Inc. Conference Call. My name is Erica, and I will be coordinator for today. At this time, all participants are in listen-only mode. We will be facilitating a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded for replay purposes. I would now like to turn the presentation over to your host for today's call, Mr. Bob Burrows, Vice President of Investor Relations. You may proceed, sir. ...

</description><pubDate>5/27/2008 4:09:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Emergent BioSolutions Inc Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">EBS</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Emergent BioSolutions Inc Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1861285</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1818013</link><guid isPermaLink="false">ccbn/T1818013</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Emergent BioSolutions Inc. -  Chairman , CEO Good morning. Can you hear me? Good morning, ladies and gentlemen. The #### Annual Meeting of Stockholders of Emergent  BioSolutions is hereby called to order. I am Fuad El-Hibri, Chairman of the Board and Chief Executive Officer of Emergent. I'm pleased to welcome you to our #### Annual Meeting of Stockholders. Looking back to ####, our first full year as a public company, we achieved financial and operational success. Financially, we achieved record revenues and were profitable for the six consecutive year. We also finished the year with over $### million in cash.Operationally, we sold more of our licensed product, BioThrax, Anthrax Vaccine Absorbed, and made forward progress in key product development programs. We also advanced our manufacturing expansion program and met important strategic objectives. I look forward to providing you with a brief update on the current status of the Company later in the meeting. When you signed in at the...

</description><pubDate>5/21/2008 5:12:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Emergent BioSolutions Inc Annual Meeting of Stockholders Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">EBS</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">10:00am ET</ccbn:time><title>Emergent BioSolutions Inc Annual Meeting of Stockholders Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1818013</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1816792</link><guid isPermaLink="false">ccbn/T1816792</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day, ladies and gentlemen, and welcome to the First Quarter #### Emergent BioSolutions Inc. Earnings Conference Call. My name is Karen and I will be your coordinator for today. At this time, all participants are in listen-only mode. We will be facilitating a question and answer session towards the end of this conference. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation -- ...

</description><pubDate>5/8/2008 8:13:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 Emergent Biosolutions Inc Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">EBS</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Q1 2008 Emergent Biosolutions Inc Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1816792</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/1318186</link><guid isPermaLink="false">bir/1318186</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Emergent BioSolutions Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">Emergent BioSolutions Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">BioPort Corp</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Emergent BioSolutions</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Pharmaceuticals, prescription drugs.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2833</bir:sic><bir:ssic xmlns:bir="http://www.alacra.com/bir">2834</bir:ssic><bir:naics xmlns:bir="http://www.alacra.com/bir">325411</bir:naics><bir:snaics xmlns:bir="http://www.alacra.com/bir">325412</bir:snaics><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">E</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">H</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">EBS</bir:ticker><pubDate>3/11/2008 6:12:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">1318186</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1771773</link><guid isPermaLink="false">ccbn/T1771773</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Good day ladies and gentlemen and welcome to the Fourth Quarter #### Emergent Biosolutions Incorporated Earnings Conference Call. My name is Frances and I'll be your coordinator for today. (OPERATOR INSTRUCTIONS) I would now like to turn the presentation over to your host for today, Mr. Bob Burrows, Vice President of Investor Relations. Please proceed. ...

</description><pubDate>3/7/2008 6:10:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 Emergent Biosolutions Inc Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">EBS</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:00am ET</ccbn:time><title>Q4 2007 Emergent Biosolutions Inc Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1771773</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1752327</link><guid isPermaLink="false">ccbn/T1752327</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Emergent Biosolutions Inc at BIO CEO &amp; Investor Conference</description><pubDate>2/11/2008 5:12:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Emergent Biosolutions Inc at BIO CEO &amp; Investor Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">EBS</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:45am ET</ccbn:time><title>Emergent Biosolutions Inc at BIO CEO &amp; Investor Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1752327</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item></channel></rss>